Categories
Articles

Google Investors Fought the "Law" and it Won

“As the size of a business grows, the percentage growth it enjoys must inevitably decline” The Law of Large Numbers

Google (GOOG) released results last Thursday and the quarter was by all accounts, outstanding. Yet shareholders got killed. What happened? The only 100% true Law of
Investing ran up against excessive epectations.

Since it has been just over a year since my first Google post on its valuation and about 8 months since the last one. I thought now would be an opportune time to revisit the topic.

For Q4, Google said profit grew 17% to $1.21 billion, or $3.79 per share, on revenue of $4.83 billion. Analysts expected profit of $4.44 per share on revenue of $5.43 billion. Traffic growth dropped to 37% in the fourth quarter from 55% in the third, despite a market-share gain. Nothing wrong with those number but, when the expectation is for far more, shares get hit, hard.

The Lemmings:
Analysts, who only in the summer and fall were tripping over each other to have the highest price target for shares, are now doing the same to reduce them. Remember the $1000 price targets?

Jefferies & Co. analyst Youssef H. Squali downgraded the company to “Hold” from “Buy” and slashed his price target to $600 from $725.

Lehman Brothers cut its price target for Google to $644 from $714.

RBC Capital Markets lowered its target to $675 from $725.

Over the past year after my post, when shares sat around $500, they have dipped as low as $450 and ran up as high as just over $700. Now, a year later on Friday they closed at $515, 3% above where they sat a year ago.

Did management screw up? No. Could they have done something different to achieve greater growth? I think you would be hard pressed to find investors in many companies that earn over $1 billion a quarter complaining about 17% growth.

This is a simple story about unrealistic expectations. Period.

Now, the bad news. At $13.28 a share in earnings the past twelve months, at $526 a share, they are trading hands at 40 times earnings(last year they were trading at 60 times). Earnings that look to be growing under 20% now going forward. Now, while 17% growth at a company the size of Google is fantastic, it sucks when investors are pricing in almost twice that in the shares.

I think we may be having the same conversation next year…

Disclosure (“none” means no position): None

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Looking at USG

As I was scanning James Cullen’s site I came across a post that intrigued me.

James wrote an analysis of USG and for the back round, here is it. Now that being said, in an interview I gave wit him, I said that I though housing was the next big value find. I also said that currently the situation was “too opaque” and that there would most likely be some builders go under. Trying to figure out who is next to impossible as the variables (land owned, where it is, local housing markets, carried value of land on books etc) are so subjective, getting a true handle on a builder is just guesswork.

So, that being said, if we do think home building is the next value area, rather than try to pick a builder, why not pick the maker of a product they all need? It really does not matter who is left standing among the builders when all this is over. No matter who it is, they will be buying wall board from USG.

That makes USG a very interesting proposition. It also does not hurt that Warren Buffett’s Berkshire Hathaway (BRK.A) owns 17% of the stock.

James did a follow-up post after the recent earnings call and the outlook for 2008 is not real rosy. But, this is a management team that has never thrown out rosy scenarios to investors in an attempt to prop up a stocks price.

It would seem that I am not the only one who thinks this way as the stock has jumped from $31.05 to $38 (22%) and change since Jan. 7th.

What to do? Well, sit and wait for now. I can’t buy anything after a 2 week 20% plus run. Now, if the stock were to give 1/2 that back, I would then become interested. Should it plop more back on the table, I would be inclined to be a buyer.

Will it? I am inclined to say yes. Housing will be a drag for a while and eventually many recent buyers will give up and move on to something else. When they do, the price ought to fall.

Disclosure (“none” means no position):None

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Monday’s Upgrades and Downgrades


Upgrades
Clear Channel (CCU)- CL King Neutral » Strong Buy
Chartered Semi (CHRT)- HSBC Securities Underweight » Neutral
Dionex (DNEX)- Wedbush Morgan Hold » Buy $74 » $83
PetroChina (PTR)- Credit Suisse Underperform » Neutral
GSI Technology (GSIT)- Stanford Research Hold » Buy
Capitol Bancorp (CBC)- FTN Midwest Sell » Neutral
Garmin (GRMN)- Needham & Co Hold » Buy
Getty Images (GYI)- William Blair Mkt Perform » Outperform
MFA Mortgage (MFA)- Stifel Nicolaus Hold » Buy
Anworth Mortgage (ANH)- Stifel Nicolaus Hold » Buy
Bristol-Myers (BMY)- Cowen & Co Neutral » Outperform
CA Inc (CA)- RBC Capital Mkts Sector Perform » Outperform
DIRECTV (DTV)- Bernstein Mkt Perform » Outperform
Frontier Oil (FTO)- Soleil Hold » Buy
Valero Energy (VLO)- Soleil Hold » Buy
Flowserve (FLS)- Bear Stearns Peer Perform » Outperform
Maxim Integrated (MXIM)- Bear Stearns Peer Perform » Outperform
Clear Channel Outdoor (CCO)- Bear Stearns Peer Perform » Outperform
Celestica (CLS) Credit Suisse Underperform » Neutral
Motorola (MOT) Citigroup Hold » Buy
Affiliated Computer (ACS)- RBC Capital Mkts Sector Perform » Outperform
PepsiAmericas (PAS)- Bear Stearns Underperform » Peer Perform
Electronic Arts (ERTS)- Broadpoint Capital Neutral » Buy
Autoliv (ALV)- Deutsche Securities Hold » Buy
Owens-Illinois (OI)- Deutsche Securities Hold » Buy
GlaxoSmithKline (GSK)- HSBC Securities Underweight » Neutral
Medarex (MEDX)- Banc of America Sec Sell » Neutral
Infinera (INFN)- Jefferies & Co Hold » Buy
Walt Disney (DIS)- Oppenheimer Perform » Outperform

Downgrades
Cerner (CERN)- Canaccord Adams Buy » Hold
AmericanWest Banc (AWBC)- DA Davidson Buy » Neutral
Maxim Integrated (MXIM)- UBS Buy » Neutral
Maxim Integrated (MXIM)- Deutsche Securities Buy » Hold
Yahoo! (YHOO)- Susquehanna Financial Positive » Neutral
RF Micro Device (RFMD)- Needham & Co Strong Buy » Buy
Maxim Integrated (MXIM)- William Blair Mkt Perform » Underperform
TiVo (TIVO)- William Blair Mkt Perform » Underperform
Newell Rubbermaid (NWL)- BMO Capital Markets Outperform » Market Perform
Landstar System (LSTR)- Stifel Nicolaus Buy » Hold
Avid Tech (AVID)- Kaufman Bros Hold » Sell
American Express (AXP)- Sandler O’Neill Buy » Hold
Maxim Integrated (MXIM)- Citigroup Buy » Sell
Exar (EXAR)- Piper Jaffray Buy » Neutral
St. Mary Lnd/Expl (SM )- KeyBanc Capital Mkts Buy » Hold
Trident Microsystems (TRID)- Roth Capital Hold » Sell
Maxim Integrated (MXIM)- Jefferies & Co Buy » Hold
Google (GOOG)- Jefferies & Co Buy » Hold
FNB Corp. (NC) (FNBN)- Keefe Bruyette Outperform » Mkt Perform
United Dominion (UDR)- Keefe Bruyette Outperform » Mkt Perform
Audible (ADBL)- Citigroup Buy » Hold
Syngenta (SYT)- UBS Neutral » Sell
Lowe’s (LOW )-Citigroup Buy » Hold
AstraZeneca (AZN)- HSBC Securities Overweight » Neutral
Mentor Corp (MNT)- Merriman Curhan Ford Buy » Neutral
TiVo (TIVO)- Friedman Billings Mkt Perform » Underperform

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

CHOKE

After being anointed “Dynasty”, “Best Team in History” and made 13.5 point favorites the minute the match-up was set, Brady and company can now ad another moniker, “Chokers”. This was the largest upset in Super Bowl history by far. Maybe the Pat’s ran out of tape to video the Giant’s with?

On the minus side, we now get more video of the insufferable Shula and his Dolphin’s sipping champaign another year.

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

"Fast Money" for Monday


Monday’s Picks
Tim Seymour recommends SPDR S&P Emerging Middle East & Africa ETF (GAF) $66.0

Karen Finerman prefers Yahoo! (YHOO) $28.38

Pete Najarian thinks Biogen (BIIB) $61.76 is a buy.

Friday’s Results
Jeff Macke likes Google (GOOG) $564.3 but says to get out if it drops to a 4-handle. Close $$515 LOSS

Guy Adami prefers McDonald’s (MCD) $53.58 Close $54.22 GAIN

Pete Najarian thinks Alpha Natural Resrouces (ANR) $33.42 is a buy. Close $35.11 GAIN

Karen Finerman recommends Broadridge Financial (BR) $21.66 Close $22.52 GAIN

2008 Records:
Brian Schaeffer= 0-1
Carter Worth= 0-1
Jon Najarian= 3-1
Jeff Macke= 7-5
Tim Seymore= 2-1
Guy Adami= 7-8
Pete Najarian= 7-5
Karen Finerman= 6-6

2007 Results (Since 6/21):
Guy Adami= 58-46 = 56%
Jeff Macke= 60-40 = 60%
Pete Najarian= 49-41 = 54%
Karen Finerman= 40-30 = 57%

Disclosure (“none” means no position):

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Altria and UST: Why Now?

Rumors are circulating that the “financial flexibility to respond to opportunites” Altria’s (MO) Louis Camilleri was alluding to last week means that the company is going to acquire UST (UST). I am not so sure…

According to an article in Reuters
“The writing is on the wall, and has been on the wall for years, that this was the inevitable combination,” said one consumer investment banker, who declined to be named.

“Altria has made no secret of its intentions for the smokeless market. But Altria had a lot of steps to make before they could make a move. Of course, in that time, UST’s prize smokeless business has deteriorated some,” the banker said.

All of the above is true, but, if Altria has had the acquisition in mind for years, why would they have spent millions developing and testing their own product? wouldn’t it just have made sense to make the purchase of UST before?

I do not believe any delay in a potential purchase had anything to do with the recently announced PMI spin. Both Phillip Morris USA (PMUSA) and Phillip Morris International (PMI) have made acquisitions during the past few year. As a matter of fact as recently as last fall PMUSA announced they were buying cigar maker John Middleton.

Further, if UST is facing declining usage of it products (they are), then why make the move now? Altria’s own smokeless products are virtually set to be rolled out nationally and based on the latest conference call, Camilleri was almost giddy over the results to date and the products potential.

Assuming Camilleri is not lying, wouldn’t the prudent thing to do be to wait? Let your products further erode UST’s smokeless business even more and then correspondingly watch the price you have to pay for UST to decline in tandem?

What if Camilleri’s enthusiasm if warranted and Altria has a massive hit on its hand? They would in effect take a giant swath of business from UST and any price paid today, would look excessive down the road.

It isn’t that a potential purchase of UST would be bad for Altria (it would be great), it is that the timing of doing it now just would not seem to make a whole lot of sense. It would seem that doing it a year or so ago or a year or two from now would be a far more economically sound decision.

Disclosure (“none” means no position): Long MO, None

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

ADM Reports Monday

Archer Daniels Midland (ADM) the world’s largest biofuel and food processor reports earnings tomorrow.

The estimates are for $0.74 EPS on $12.65 Billion in revenues. Estimates for fiscal June 2008 are $2.70 EPS on $52.27 billion in revenues.

Now, it is important to note that earnings estimates have been trending higher for both the quarter and 2008 as a whole. Initial estimates failed to properly take into account the full scope of ADM’s earnings. While high corn prices may hurt ethanol margins, the increases are easily passed along to HFCS buyers. Also, ADM is a huge exported of the commodity and its trading operations saw significant gains also.

As the world “modernizes”, ADM benefits. Operating the world’s most diverse and well established procurement and supply operations of food commodities, ADM is perfectly positioned to ride the boom in both biofuels, and food.

I expect ADM to beat the $.74 cent estimates. 80 cents a share seems to be a more legitimate number given what is happening with food. Ethanol margins will not be stellar but to be honest, they have to contract. Ethanol will become like gasoline. It will be a production item, not a margin one. The largest producers will make the most just like in the gasoline game. ADM, with 1.1 billion gallons annually now is already the largest and they have another 500 mgpy coming online soon.

On the earnings call we will want:
– Updates on the several expansion project (ethanol, biodiesel, cocoa) they have currently.
– ADM has been rumored to be in the market as a acquirer, any progress? When do they see themselves entering the Brazilian market?
– Do they have their sites set on Verasun (VSE), Pacific Ethanol (PEIX) or the Andersons (ANDE)? I doubt PEIX, but, the other two could be good choices for logistical reasons.
– ADM has also been rumored as an acquisition target, can we put it to bed?
– Cellulose ethanol. We all know this is doable. It is being done on a small scale currently. Any progress on larger, commercially viable processes?
– US biodiesel market. How is it progressing? Do they expect any meaningful expansion of the US market?
– Surprise us….

Disclosure (“none” means no position): Long ADM, None

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Traffic Generators

Here are the top website referrers to ValuePlays for the month of January.

1- finance.google.com

2- www.valueinvestingnews.com

3- www.stockpickr.com

4- www.seekingalpha.com

5- online.wsj.com

6- www.google.com

7- studio-5.financialcontent.com

8- blogs.wsj.com

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Interview with "The College Analysts"

James Cullen who runs the College Analysts investing site recently asked me 10 questions.

You can see the interview here:

If you have not visited the site yet, Please at least check out James’ report on USG (USG), it is a fantastic read and I am starting to think it may be the best way to play the housing crunch rebound.

Disclosure (“none” means no position):None

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

ValuePlays Most Read Posts for January

1- Ackman’s Letter to Moody’s: A Must Read

2- Lampert’s Move: Yes, Its About Brands

3- DeBeers Diamond Refunds

4- Lampert’s Letter to Associates: “No Direct Reports”

5- Altria Releases Spin Details

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

The Week’s Top Stories at Value Investing News

Here they are, the Top 20 from VIN

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

The Weeks Dividend Increases


Capital One Fin’l-(COF) = 1309.8 %
Brooklyn Fedl Bncp Inc-(BFSB)= 40.0%
Airgas Inc-(ARG )= 33.3 %
United States Steel Corp-(X)= 25.0%
Fluor Corp-(FLR) 25.0%
Alliance Bancorp PA-(ALLB)= 20.0%
Alberto-Culver Co-(ACV)= 18.2%
Targa Res PrtnrsL.P-(NGLS) 17.8%
Lehman Bros-(LEH)= 13.3%
GATX Corp-(GMT) 12.5%
Lazard Ltd-(LAZ)= 11.1%
Timberland Bancorp-(TSBK) = 10.05

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

The Week’s Insider Buys


Coldwater Creek Inc (CWTR)= $ 9,606,000
Luby S Inc LUB 1 600,000 5,400
Xtl Biopharmaceuticals Ltd (XTLB) = $ 5,070,000
Citigroup Inc (C) = $4,998,000
Raymond James Financial Inc (RJF)= $ 2,987,000
Cenveo Inc (CVO) = $2,900,000
Equity One Inc (EQY)= $2,705,000
At&T Inc (T ) = $2,274,000
Johnson Controls Inc (JCI)= $2,121,000
E Trade Financial Corp (ETFC) = $1,929,000
Lions Gate Entertainment Corp (LGF) = $ 1,829,000

Disclosure (“none” means no position):

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

52 Week Low’s 2/1


(URX)= United Refining Energ …
(UNCA )= Unica Corp
(TXA )= Tribune Co New
(PCOP )= Pharmacopeia Inc
(PCBI )= Peoples Cmnty Bancorp Inc
(OMRI )= Omrix Biopharmaceutic …
(MRX)= Medicis Pharmaceutica …
(MROE )= Monroe Bancorp
(MAYS )= J W Mays Inc
(LIMC )= Limco Piedmont Inc
(KWK )= Quicksilver Resources Inc
(INTT )= Intest Corp
(BFRM )= Bioform Medical Inc
(BCRX )= BioCryst Pharmaceutic …
(AZN )= Astrazeneca Plc
(AWBC )= Americanwest Bancorpo …
(AVID )= Avid Technology Inc
(ARAY )= Accuray Inc

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books

Categories
Articles

Icahn Buys Into JC Penny?

A report in the WSJ today said the stake is among Mr. Icahn’s top five holdings, which could mean it runs into the hundreds of millions of dollar.

Icahn will disclose the stake in mid-Feb according to the story. Now, Carl is scheduled to appear on CNBC’s “Fast Money” show today at 5pm. If he is not going to disclosed the stake until the next couple weeks, it is unlikely we will get any details tonight on the show.

JC Pennys’ stock, like rival retailers such as Sears Holdings (SHLD), Macy’s (M) and Kohl’s (KSS) is down over 40% in the last year and trades at just under 10 times earnings.

Disclosure (“none” means no position):None, Long SHLD

Todd Sullivan's- ValuePlays

↑ Grab this Headline Animator

Visit the ValuePlays Bookstore for Great Investing Books